Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Doximity (DOCS) Research & Development (2020 - 2025)

Historic Research & Development for Doximity (DOCS) over the last 6 years, with Q4 2025 value amounting to $34.6 million.

  • Doximity's Research & Development rose 5429.73% to $34.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $116.4 million, marking a year-over-year increase of 3169.84%. This contributed to the annual value of $93.0 million for FY2025, which is 1348.45% up from last year.
  • Per Doximity's latest filing, its Research & Development stood at $34.6 million for Q4 2025, which was up 5429.73% from $30.2 million recorded in Q3 2025.
  • Doximity's 5-year Research & Development high stood at $34.6 million for Q4 2025, and its period low was $12.6 million during Q1 2021.
  • For the 5-year period, Doximity's Research & Development averaged around $21.1 million, with its median value being $20.3 million (2022).
  • As far as peak fluctuations go, Doximity's Research & Development skyrocketed by 5669.98% in 2021, and later plummeted by 646.67% in 2024.
  • Doximity's Research & Development (Quarter) stood at $16.2 million in 2021, then rose by 26.47% to $20.5 million in 2022, then fell by 2.79% to $19.9 million in 2023, then rose by 12.41% to $22.4 million in 2024, then skyrocketed by 54.3% to $34.6 million in 2025.
  • Its Research & Development was $34.6 million in Q4 2025, compared to $30.2 million in Q3 2025 and $26.8 million in Q2 2025.